乳腺癌前哨淋巴结活检假阴性相关因素与对策

　　新辅助化疗（NAC）主要用于局部晚期的乳腺癌患者，可在术前降低肿瘤分期，减少阳性腋窝淋巴结（ALN）的数量。研究证实，NAC可使约1/3的ALN阳性患者转为阴性，可降低约55%的患者的淋巴结分期。

Oncologist.;20(4):-43.

NoadjuvantDualHER2-TargtdThrapyWithLapatinibandTrastuzumabImprovsPathologicCompltRsponsinPatintsWithEarlyStagHER2-PositivBrastCancr:AMta-AnalysisofRandomizdProspctivClinicalTrials.

HicksM,MacraER,Abdl-RasoulM,LaymanR,FridmanS,QurryJ,LustbrgM,RamaswamyB,MrozkE,ShapiroC,WsolowskiR.

ThJamsCancrHospitalandRichardSolovRsarchInstitut,ThOhioStatUnivrsityComprhnsivCancrCntr,Columbus,Ohio,USA.

BACKGROUND:Randomizdclinicaltrials(RCT)thatvaluatdthadditionoflapatinibtotrastuzumabplusnoadjuvantchmothrapy(NAC)inpatintswithHER2-positiv,oprablbrastcancrrvaldaqustionablimprovmntinpathologic







































皮肤病最好医院
治疗白癜风出名医院